Cite
HARVARD Citation
Naganuma, M. et al. (2022). Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis. Journal of gastroenterology and hepatology. 37 (1), pp. 81-88. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Naganuma, M. et al. (2022). Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis. Journal of gastroenterology and hepatology. 37 (1), pp. 81-88. [Online].